May 6, 2024
Our practice has started recruiting for the MAKO clinical trial, a phase III study for newly diagnosed wet age-related macular degeneration patients. Patients will receive compensated anti-VEGF Lucentis injections with […]
Read MoreAug 15, 2024
VRMNY is recruiting patients for the BOULEVARD study, a Phase II clinical trial for newly diagnosed diabetic macular edema (DME). Patients will be randomized to receive standard anti-VEGF Lucentis injections […]
Read MoreLet us help you enjoy your life
Call: (212) 861-9797To Speak With An Appointment Coordinator Now